Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE)
- Conditions
- HIV Medication AdherenceMethamphetamine UseSexual RiskPoly-substance UseHIV Infections
- Interventions
- Behavioral: Motivational Interviewing + Cognitive Behavioral Skills TrainingBehavioral: Education Attention Control
- Registration Number
- NCT01122186
- Lead Sponsor
- Hunter College of City University of New York
- Brief Summary
The primary aim is to test an innovative 8-session intervention, based on Motivational Interviewing and Cognitive Behavioral Skills-Training for the co-occurrence of methamphetamine use and highly active antiretroviral therapy (HAART) non-adherence among methamphetamine using HIV+ MSM in NYC, compared to an 8-session educational (ED) condition. Participants in the intervention condition will report greater reductions in the number of days of methamphetamine use and viral load, and greater increases in CD4 counts and self-reported and objectively measured adherence than those in the education condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 210
- HIV+ (confirmed at baseline through documentation)
- Biologically male
- report sex with another man at least once
- report methamphetamine use at least three times in the past three months
- report less than 90% HAART medication adherence, as measured by the total number of days a participant missed an HIV medication in the last 30
- able to communicate with staff and complete a survey that is in English.
- Unstable, serious psychiatric symptoms
- Currently suicidal/homicidal
- Evidence of gross cognitive impairment
- Self-reported current enrollment in a drug or HIV-related intervention or research study.
- Methadone use
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Condition Motivational Interviewing + Cognitive Behavioral Skills Training Eight sessions of Motivational Interviewing and Cognitive Behavioral Skills Training, adapted to target both MA use and medication adherence, as well as sexual risk behaviors and polydrug use. Education Condition Education Attention Control Eight sessions of education with content designed to mirror the information covered in the intervention condition. The content will be as follows: 3 sessions focusing on medication adherence; 3 sessions focusing on the dangers of methamphetamine use; 1 session addressing sexual risk; and 1 session addressing poly-substance use.
- Primary Outcome Measures
Name Time Method Adherence to HIV medication every three months over the course of a year Participants in the intervention condition will report greater reductions in viral load, and greater increases in CD4 counts and self-reported adherence than those in the education comparison at at the end of the intervention period (3 months). Those in the intervention condition will also maintain greater reductions in viral load, and greater increases in CD4 counts and self-reported adherence than those in the education comparison condition at the three follow-up assessments (6, 9, and 12 months).
Methamphetamine use. every three months over the course of a year Participants in the intervention condition will report greater reductions in self-reported days of methamphetamine use than those in the education comparison at at the end of the intervention period (3 months). Those in the intervention condition will also maintain greater reductions in self-reported days of methamphetamine use than those in the education comparison condition at the three follow-up assessments (6, 9, and 12 months).
- Secondary Outcome Measures
Name Time Method Sexual Risk every three months over the course of a year Participants in the intervention condition will report greater reductions in high-risk sexual behavior compared to participants in the educational comparison condition.
Polysubstance use every three months over the course of a year Participants in the intervention condition will report greater reductions in the use of substances other than methamphetamine, compared to participants in the educational comparison condition.
Trial Locations
- Locations (1)
Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY
🇺🇸New York, New York, United States